Patents by Inventor Jong-Min Han

Jong-Min Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of glycine max leaves or fractions isolated from the same as an active ingredient
    Patent number: 9381222
    Abstract: The present invention relates to compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of Glycine max leaves or fractions isolated from the same.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: July 5, 2016
    Assignee: Korea Reasearch Institute of Bioscience and Biotechnology
    Inventors: Tae-Sook Jeong, Woo Song Lee, Ki Hun Park, Myung-Sook Choi, Ho Yong Park, Jong-Min Han, Hyung-Jae Jeong
  • -acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease
    Patent number: 8399662
    Abstract: The present invention relates to novel O-acyloxime derivatives, a preparation method thereof and a pharmaceutical composition comprising the same for prevention and treatment of cardiovascular disease. The O-acyloxime derivatives according to the present invention may valuably be used for prevention and treatment of cardiovascular diseases such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction caused by Lp-PLA2, because they have excellent inhibitory effect of Lp-PLA2.
    Type: Grant
    Filed: November 9, 2009
    Date of Patent: March 19, 2013
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Tae-Sook Jeong, Woo-Song Lee, Hyung-Jae Jeong, Yong-Dae Park, Jong-Min Han, Hyoung-Chin Kim, Og-Sung Moon, Young-Suk Won
  • Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease
    Patent number: 8362034
    Abstract: The present invention relates to a composition for the prevention and treatment of cardiovascular diseases containing the novel quinoline compound, the centipede extracts or compounds isolated from the extracts. The novel quinoline compound, the centipede extracts or a quinoline compound and a phenol compound isolated from the extracts of the invention exhibit excellent LDL-antioxidant activity, ACAT inhibiting activity, and anti-inflammatory activities, so that they can be included as an effective ingredient in a composition for the prevention and treatment of cardiovascular disease including hyperlipidemia, atherosclerosis, coronary heart disease, and myocardial infarction mediated by LDL-oxidation, cholesteryl ester synthesis and accumulation, and inflammation.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: January 29, 2013
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Ho Yong Park, Tae-Sook Jeong, Hyun-Woo Oh, Woo-Song Lee, Doo-Sang Park, Jong-Min Han
  • NOVEL QUINOLINE COMPOUND, AND COMPOSITION CONTAINING CENTIPEDE EXTRACT OR COMPOUNDS ISOLATED THEREFROM FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20120220626
    Abstract: The present invention relates to a composition for the prevention and treatment of cardiovascular diseases containing the novel quinoline compound, the centipede extracts or compounds isolated from the extracts. The novel quinoline compound, the centipede extracts or a quinoline compound and a phenol compound isolated from the extracts of the invention exhibit excellent LDL-antioxidant activity, ACAT inhibiting activity, and anti-inflammatory activities, so that they can be included as an effective ingredient in a composition for the prevention and treatment of cardiovascular disease including hyperlipidemia, atherosclerosis, coronary heart disease, and myocardial infarction mediated by LDL-oxidation, cholesteryl ester synthesis and accumulation, and inflammation.
    Type: Application
    Filed: May 2, 2012
    Publication date: August 30, 2012
    Inventors: Ho Yong PARK, Tae-Sook JEONG, Hyun-Woo OH, Woo-Song LEE, Doo-Sang PARK, Jong-Min HAN
  • Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease
    Patent number: 8212042
    Abstract: The present invention relates to a composition for the prevention and treatment of cardiovascular diseases containing the novel quinoline compound, the centipede extracts or compounds isolated from the extracts. The novel quinoline compound, the centipede extracts or a quinoline compound and a phenol compound isolated from the extracts of the invention exhibit excellent LDL-antioxidant activity, ACAT inhibiting activity, and anti-inflammatory activities, so that they can be included as an effective ingredient in a composition for the prevention and treatment of cardiovascular disease including hyperlipidemia, atherosclerosis, coronary heart disease, and myocardial infarction mediated by LDL-oxidation, cholesteryl ester synthesis and accumulation, and inflammation.
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: July 3, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Ho Yong Park, Tae-Sook Jeong, Hyun-Woo Oh, Woo-Song Lee, Doo-Sang Park, Jong-Min Han
  • Compositions for Preventing and Treating Obesity, Hyperlipidemia, Atherosclerosis, Fatty Liver, Diabetes or Metabolic Syndrome Containing Extracts of Glycine Max Leaves or Fractions Isolated from the Same as an Active Ingredient
    Publication number: 20100291248
    Abstract: The present invention relates to compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of Glycine max leaves or fractions isolated from the same.
    Type: Application
    Filed: November 10, 2009
    Publication date: November 18, 2010
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Tae-Sook Jeong, Woo Song Lee, Ki Hun Park, Myung-Sook Choi, Ho Yong Park, Jong-Min Han, Hyung-Jae Jeong
  • NOVEL O-ACYLOXIME DERIVATIVES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20100056780
    Abstract: The present invention relates to novel O-acyloxime derivatives, a preparation method thereof and a pharmaceutical composition comprising the same for prevention and treatment of cardiovascular disease. The O-acyloxime derivatives according to the present invention may valuably be used for prevention and treatment of cardiovascular diseases such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction caused by Lp-PLA2, because they have excellent inhibitory effect of Lp-PLA2.
    Type: Application
    Filed: November 9, 2009
    Publication date: March 4, 2010
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Tae-Sook JEONG, Woo-Song LEE, Hyung-Jae JEONG, Yong-Dae PARK, Jong-Min HAN, Hyoung-Chin KIM, Og-Sung MOON, Young-Suk WON
  • -acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease
    Patent number: 7642291
    Abstract: The present invention relates to novel O-acyloxime derivatives, a preparation method thereof and a pharmaceutical composition comprising the same for prevention and treatment of cardiovascular disease. The O-acyloxime derivatives according to the present invention may valuably be used for prevention and treatment of cardiovascular diseases such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction caused by Lp-PLA2, because they have excellent inhibitory effect of Lp-PLA2.
    Type: Grant
    Filed: October 17, 2005
    Date of Patent: January 5, 2010
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Tae-Sook Jeong, Woo-Song Lee, Hyung-Jae Jeong, Yong-Dae Park, Jong-Min Han, Hyoung-Chin Kim, Og-Sung Moon, Young-Suk Won
  • Novel Quinoline Compound, and Composition Containing Centipede Extract or Compounds Isolated Therefrom for Prevention and Treatment of Cardiovascular Disease
    Publication number: 20090247758
    Abstract: The present invention relates to a composition for the prevention and treatment of cardiovascular diseases containing the novel quinoline compound, the centipede extracts or compounds isolated from the extracts. The novel quinoline compound, the centipede extracts or a quinoline compound and a phenol compound isolated from the extracts of the invention exhibit excellent LDL-antioxidant activity, ACAT inhibiting activity, and anti-inflammatory activities, so that they can be included as an effective ingredient in a composition for the prevention and treatment of cardiovascular disease including hyperlipidemia, atherosclerosis, coronary heart disease, and myocardial infarction mediated by LDL-oxidation, cholesteryl ester synthesis and accumulation, and inflammation.
    Type: Application
    Filed: May 19, 2006
    Publication date: October 1, 2009
    Inventors: Ho Yong Park, Tae-Sook Jeong, Hyun-Woo Oh, Woo-Song Lee, Doo-Sang Park, Jong-Min Han
  • NOVEL O-ACYLOXIME DERIVATIVES, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20060106017
    Abstract: The present invention relates to novel O-acyloxime derivatives, a preparation method thereof and a pharmaceutical composition comprising the same for prevention and treatment of cardiovascular disease. The O-acyloxime derivatives according to the present invention may valuably be used for prevention and treatment of cardiovascular diseases such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction caused by Lp-PLA2, because they have excellent inhibitory effect of Lp-PLA2.
    Type: Application
    Filed: October 17, 2005
    Publication date: May 18, 2006
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Tae-Sook JEONG, Woo-Song LEE, Hyung-Jae JEONG, Yong-Dae PARK, Jong-Min HAN, Hyoung-Chin KIM, Og-Sung MOON, Young-Suk WON